Page breadcrumb nav

VAERS Report 2156756

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2021-11-12
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

psoriatic/psoriatic arthritis aggravated/psoriatic reaction was continuing to spread, primary location was lower legs; guttate psoriasis; primary immunization : unknown manufacturer, at least one was non- pfizer vaccine and booster: comirnaty; primary immunization : unknown manufacturer, at least one was non- pfizer vaccine and booster: comirnaty; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency (ra). regulatory number: gb-mhra-webcovid-202202160841217200-rtlxw (ra). other case identifier(s): gb-mhra-adr 26609188 (ra). a 62 year-old female patient received bnt162b2 (comirnaty), administration date 12nov2021 (batch/lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. relevant medical history included: "trigeminal neuralgia" (unspecified if ongoing); "psoriatic arthritis" (unspecified if ongoing); "osteoarthritis" (unspecified if ongoing); "fibromyalgia" (unspecified if ongoing); "gerd" (unspecified if ongoing); "immunodeficiency" (unspecified if ongoing), notes: has an illness or condition, not listed above, which reduces the immune response; "high blood pressure" (unspecified if ongoing); "laryngopharyngeal reflux" (unspecified if ongoing), notes: lpr. patient had not had symptoms associated with covid-19. the patient's concomitant medications were not reported. vaccination history included: covid 19 vaccine (dose 2; manufacturer unknown), for covid-19 immunisation; covid 19 vaccine (dose 1; manufacturer unknown), for covid-19 immunisation. the following information was reported: off label use (medically significant), interchange of vaccine products (medically significant) all with onset 12nov2021, outcome "unknown" and all described as "primary immunization : unknown manufacturer, at least one was non- pfizer vaccine and booster: comirnaty"; psoriatic arthropathy (medically significant), outcome "not recovered", described as "psoriatic/psoriatic arthritis aggravated/psoriatic reaction was continuing to spread, primary location was lower legs"; guttate psoriasis (medically significant) with onset 27nov2021, outcome "not recovered", described as "guttate psoriasis". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: no - negative. the clinical course was reported as follows: as of 16feb2022, psoriatic reaction was continuing to spread, primary location was lower legs. the patient had not been tested positive for covid-19 since having the vaccine. patient was not enrolled in clinical trial. this report was not related to possible inflammation of the heart (myocarditis or pericarditis). no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Données de laboratoire
test name: covid-19 virus test; result unstructured data: test result:no - negative
Liste des symptômes
interchange of vaccine products sars-cov-2 test off label use guttate psoriasis psoriatic arthropathy
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na